Valcyte

Rediff.com » News » Valcyte

News for Valcyte

Business

Why Sun Pharma stock will remain under pressure

The weakness in the stock was because of inspections by the American drug regulator at its Halol plant in Gujarat which resulted in eight observations, as well as a downward revision of speciality......

Markets end in green amid volatile trade

The S&P BSE Sensex ended up 45 points at 25330 and the Nifty50 closed 11 points higher at 7,715. In the broader markets, the BSE Midcap and Smallcap indices ended up 0.3%-0.5% each. “Recently......

Ranbaxy brand may fade away as Sun takes charge

The Ranbaxy brand might be gradually phased out in the near future in the wake of this year’s largest merger in the Asian pharma sector. After Monday’s conditional nod from the......

US court rejects Ranbaxy' plea to block launch by rival cos

A US court has denied a request by drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc's heartburn pill Nexium and Roche's antiviral Valcyte, a court......

US FDA conducts surprise inspection of Dr Reddy's Vizag plant

The FDA has been tightening its monitoring of Indian pharma majors over compliance issues. Surprise plant inspections and import alerts have been frequent outcomes The US Food & Drug Administration......

Rediff News

Valcyte

News for Valcyte

Why Sun Pharma stock will remain under pressure

Markets end in green amid volatile trade

Ranbaxy brand may fade away as Sun takes charge

US court rejects Ranbaxy' plea to block launch by rival cos

US FDA conducts surprise inspection of Dr Reddy's Vizag plant

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS